96 related articles for article (PubMed ID: 20823288)
1. Hexadecyloxypropyl-cidofovir (CMX001) suppresses JC virus replication in human fetal brain SVG cell cultures.
Jiang ZG; Cohen J; Marshall LJ; Major EO
Antimicrob Agents Chemother; 2010 Nov; 54(11):4723-32. PubMed ID: 20823288
[TBL] [Abstract][Full Text] [Related]
2. Selection and recombinant phenotyping of a novel CMX001 and cidofovir resistance mutation in human cytomegalovirus.
James SH; Price NB; Hartline CB; Lanier ER; Prichard MN
Antimicrob Agents Chemother; 2013 Jul; 57(7):3321-5. PubMed ID: 23650158
[TBL] [Abstract][Full Text] [Related]
3. Structural basis of human mpox viral DNA replication inhibition by brincidofovir and cidofovir.
Xu Y; Wu Y; Wu X; Zhang Y; Yang Y; Li D; Yang B; Gao K; Zhang Z; Dong C
Int J Biol Macromol; 2024 Jun; 270(Pt 2):132231. PubMed ID: 38735603
[TBL] [Abstract][Full Text] [Related]
4. JC Virus Infects Neurons and Glial Cells in the Hippocampus.
Wüthrich C; Batson S; Anderson MP; White LR; Koralnik IJ
J Neuropathol Exp Neurol; 2016 Aug; 75(8):712-717. PubMed ID: 27297673
[TBL] [Abstract][Full Text] [Related]
5. JC Virus in Kidney Transplant Population: Are We Cautious Enough?
Pjanic M; Aleckovic-Halilovic M; Basic-Jukic N
J Clin Med; 2024 Apr; 13(8):. PubMed ID: 38673491
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of ODE-Bn-PMEG, an acyclic nucleoside phosphonate prodrug, as an antiviral against productive HPV infection in 3D organotypic epithelial cultures.
Banerjee NS; Wang HK; Beadle JR; Hostetler KY; Chow LT
Antiviral Res; 2018 Feb; 150():164-173. PubMed ID: 29287913
[No Abstract] [Full Text] [Related]
7. In Support of a Patient-Driven Initiative and Petition to Lower the High Price of Cancer Drugs.
Tefferi A; Kantarjian H; Rajkumar SV; Baker LH; Abkowitz JL; Adamson JW; Advani RH; Allison J; Antman KH; Bast RC; Bennett JM; Benz EJ; Berliner N; Bertino J; Bhatia R; Bhatia S; Bhojwani D; Blanke CD; Bloomfield CD; Bosserman L; Broxmeyer HE; Byrd JC; Cabanillas F; Canellos GP; Chabner BA; Chanan-Khan A; Cheson B; Clarkson B; Cohn SL; Colon-Otero G; Cortes J; Coutre S; Cristofanilli M; Curran WJ; Daley GQ; DeAngelo DJ; Deeg HJ; Einhorn LH; Erba HP; Esteva FJ; Estey E; Fidler IJ; Foran J; Forman S; Freireich E; Fuchs C; George JN; Gertz MA; Giralt S; Golomb H; Greenberg P; Gutterman J; Handin RI; Hellman S; Hoff PM; Hoffman R; Hong WK; Horowitz M; Hortobagyi GN; Hudis C; Issa JP; Johnson BE; Kantoff PW; Kaushansky K; Khayat D; Khuri FR; Kipps TJ; Kripke M; Kyle RA; Larson RA; Lawrence TS; Levine R; Link MP; Lippman SM; Lonial S; Lyman GH; Markman M; Mendelsohn J; Meropol NJ; Messinger Y; Mulvey TM; O'Brien S; Perez-Soler R; Pollock R; Prchal J; Press O; Radich J; Rai K; Rosenberg SA; Rowe JM; Rugo H; Runowicz CD; Sandmaier BM; Saven A; Schafer AI; Schiffer C; Sekeres MA; Silver RT; Siu LL; Steensma DP; Stewart FM; Stock W; Stone R; Storb R; Strong LC; Tallman MS; Thompson M; Ueno NT; Van Etten RA; Vose JM; Wiernik PH; Winer EP; Younes A; Zelenetz AD; LeMaistre CA
Mayo Clin Proc; 2015 Aug; 90(8):996-1000. PubMed ID: 26211600
[No Abstract] [Full Text] [Related]
8. Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis.
; Beecham AH; Patsopoulos NA; Xifara DK; Davis MF; Kemppinen A; Cotsapas C; Shah TS; Spencer C; Booth D; Goris A; Oturai A; Saarela J; Fontaine B; Hemmer B; Martin C; Zipp F; D'Alfonso S; Martinelli-Boneschi F; Taylor B; Harbo HF; Kockum I; Hillert J; Olsson T; Ban M; Oksenberg JR; Hintzen R; Barcellos LF; ; ; Agliardi C; Alfredsson L; Alizadeh M; Anderson C; Andrews R; Søndergaard HB; Baker A; Band G; Baranzini SE; Barizzone N; Barrett J; Bellenguez C; Bergamaschi L; Bernardinelli L; Berthele A; Biberacher V; Binder TM; Blackburn H; Bomfim IL; Brambilla P; Broadley S; Brochet B; Brundin L; Buck D; Butzkueven H; Caillier SJ; Camu W; Carpentier W; Cavalla P; Celius EG; Coman I; Comi G; Corrado L; Cosemans L; Cournu-Rebeix I; Cree BA; Cusi D; Damotte V; Defer G; Delgado SR; Deloukas P; di Sapio A; Dilthey AT; Donnelly P; Dubois B; Duddy M; Edkins S; Elovaara I; Esposito F; Evangelou N; Fiddes B; Field J; Franke A; Freeman C; Frohlich IY; Galimberti D; Gieger C; Gourraud PA; Graetz C; Graham A; Grummel V; Guaschino C; Hadjixenofontos A; Hakonarson H; Halfpenny C; Hall G; Hall P; Hamsten A; Harley J; Harrower T; Hawkins C; Hellenthal G; Hillier C; Hobart J; Hoshi M; Hunt SE; Jagodic M; Jelčić I; Jochim A; Kendall B; Kermode A; Kilpatrick T; Koivisto K; Konidari I; Korn T; Kronsbein H; Langford C; Larsson M; Lathrop M; Lebrun-Frenay C; Lechner-Scott J; Lee MH; Leone MA; Leppä V; Liberatore G; Lie BA; Lill CM; Lindén M; Link J; Luessi F; Lycke J; Macciardi F; Männistö S; Manrique CP; Martin R; Martinelli V; Mason D; Mazibrada G; McCabe C; Mero IL; Mescheriakova J; Moutsianas L; Myhr KM; Nagels G; Nicholas R; Nilsson P; Piehl F; Pirinen M; Price SE; Quach H; Reunanen M; Robberecht W; Robertson NP; Rodegher M; Rog D; Salvetti M; Schnetz-Boutaud NC; Sellebjerg F; Selter RC; Schaefer C; Shaunak S; Shen L; Shields S; Siffrin V; Slee M; Sorensen PS; Sorosina M; Sospedra M; Spurkland A; Strange A; Sundqvist E; Thijs V; Thorpe J; Ticca A; Tienari P; van Duijn C; Visser EM; Vucic S; Westerlind H; Wiley JS; Wilkins A; Wilson JF; Winkelmann J; Zajicek J; Zindler E; Haines JL; Pericak-Vance MA; Ivinson AJ; Stewart G; Hafler D; Hauser SL; Compston A; McVean G; De Jager P; Sawcer SJ; McCauley JL
Nat Genet; 2013 Nov; 45(11):1353-60. PubMed ID: 24076602
[TBL] [Abstract][Full Text] [Related]
9. CMX001 (1-O-hexadecyloxypropyl-cidofovir) inhibits polyomavirus JC replication in human brain progenitor-derived astrocytes.
Gosert R; Rinaldo CH; Wernli M; Major EO; Hirsch HH
Antimicrob Agents Chemother; 2011 May; 55(5):2129-36. PubMed ID: 21402853
[TBL] [Abstract][Full Text] [Related]
10. The validity of neuropathy and neuropathic pain measures in patients with cancer receiving taxanes and platinums.
Lavoie Smith EM; Cohen JA; Pett MA; Beck SL
Oncol Nurs Forum; 2011 Mar; 38(2):133-42. PubMed ID: 21356652
[TBL] [Abstract][Full Text] [Related]
11. Development of CMX001 (Brincidofovir) for the treatment of serious diseases or conditions caused by dsDNA viruses.
Florescu DF; Keck MA
Expert Rev Anti Infect Ther; 2014 Oct; 12(10):1171-8. PubMed ID: 25120093
[TBL] [Abstract][Full Text] [Related]
12. Revisiting JC virus and progressive multifocal leukoencephalopathy.
Rocchi A; Sariyer IK; Berger JR
J Neurovirol; 2023 Oct; 29(5):524-537. PubMed ID: 37659983
[TBL] [Abstract][Full Text] [Related]
13. An Elusive Target: Inhibitors of JC Polyomavirus Infection and Their Development as Therapeutics for the Treatment of Progressive Multifocal Leukoencephalopathy.
Kaiserman J; O'Hara BA; Haley SA; Atwood WJ
Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37239927
[TBL] [Abstract][Full Text] [Related]
14. The oncogenic roles of JC polyomavirus in cancer.
Zheng HC; Xue H; Zhang CY
Front Oncol; 2022; 12():976577. PubMed ID: 36212474
[TBL] [Abstract][Full Text] [Related]
15. Advances in the Development of Antiviral Strategies against Parvovirus B19.
Manaresi E; Gallinella G
Viruses; 2019 Jul; 11(7):. PubMed ID: 31323869
[TBL] [Abstract][Full Text] [Related]
16. Brincidofovir (CMX001) Toxicity Associated With Epithelial Apoptosis and Crypt Drop Out in a Hematopoietic Cell Transplant Patient: Challenges in Distinguishing Drug Toxicity From GVHD.
Detweiler CJ; Mueller SB; Sung AD; Saullo JL; Prasad VK; Cardona DM
J Pediatr Hematol Oncol; 2018 Aug; 40(6):e364-e368. PubMed ID: 29846280
[TBL] [Abstract][Full Text] [Related]
17. Pathologic Findings of Chronic PML-IRIS in a Patient with Prolonged PML Survival Following Natalizumab Treatment.
Himedan M; Camelo-Piragua S; Mills EA; Gupta A; Aburashed R; Mao-Draayer Y
J Investig Med High Impact Case Rep; 2017; 5(3):2324709617734248. PubMed ID: 28989935
[TBL] [Abstract][Full Text] [Related]
18. Progressive multifocal leukoencephalopathy: current treatment options and future perspectives.
Pavlovic D; Patera AC; Nyberg F; Gerber M; Liu M;
Ther Adv Neurol Disord; 2015 Nov; 8(6):255-73. PubMed ID: 26600871
[TBL] [Abstract][Full Text] [Related]
19. Brincidofovir (CMX001) inhibits BK polyomavirus replication in primary human urothelial cells.
Tylden GD; Hirsch HH; Rinaldo CH
Antimicrob Agents Chemother; 2015; 59(6):3306-16. PubMed ID: 25801568
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
